docetaxel,darolutamide
bayer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'docetaxel', 'arasens', 'darolutamide']
post-hoc analysis of arasens trial presented by dr. maha hussai in pts with mhspc, the benefits of adding darolutamide to adt + docetaxel was present regardless of disease volume and risk #gu23 
Medical oncologist. Clinical researcher focused in GU tumors. Associate Professor UCM. Hospital Clinico San Carlos Madrid, Spain